NUMIF (Numinus Wellness) Short-Term Debt: $0.05 Mil (As of May. 2025)


What is Numinus Wellness Short-Term Debt?

Numinus Wellness NUMIF -4.23% Short-Term Debt is $0.05 Mil as of May. 2025.

Numinus Wellness's Short-Term Debt for the quarter that ended in May. 2025 was $0.05 Mil.

Numinus Wellness's quarterly Short-Term Debt increased from Nov. 2024 ($0.04 Mil) to Feb. 2025 ($0.04 Mil) and increased from Feb. 2025 ($0.04 Mil) to May. 2025 ($0.05 Mil).

Numinus Wellness's annual Short-Term Debt increased from Aug. 2022 ($0.05 Mil) to Aug. 2023 ($0.05 Mil) but then declined from Aug. 2023 ($0.05 Mil) to Aug. 2024 ($0.04 Mil).

Numinus Wellness Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Numinus Wellness Short-Term Debt Related Terms

Numinus Wellness Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Numinus Wellness's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Numinus Wellness Short-Term Debt Chart

Numinus Wellness Annual Data
Trend Aug19 Aug20 Aug21 Aug22 Aug23 Aug24
Short-Term Debt
Get a 7-Day Free Trial 0.00 0.00 0.05 0.05 0.04

Numinus Wellness Quarterly Data
Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.10 0.04 0.04 0.04 0.05
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of $0.05 Mil mean?
Numinus Wellness (NUMIF) has a Short-Term Debt of $0.05 Mil as of May. 2025.
Is Numinus Wellness' Short-Term Debt too high?
Numinus Wellness' current Short-Term Debt is $0.05 Mil.
How does Numinus Wellness' Short-Term Debt compare to HLYK and SYRA?
Numinus Wellness' Short-Term Debt of $0.05 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Healthcare Providers & Services company?
A good Short-Term Debt depends on the Healthcare Providers & Services industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Numinus Wellness's current Short-Term Debt is $0.05 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Numinus Wellness stock overvalued right now?
Numinus Wellness (NUMIF) has a current Short-Term Debt of $0.05 Mil. The current Short-Term Debt is $0.05 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Numinus Wellness (NUMIF), the current Short-Term Debt is $0.05 Mil as of May. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Numinus Wellness Business Description

Address 801 - 33 Water Street, Vancouver, BC, CAN, V6B 1R4
Numinus Wellness Inc develops proprietary, psychedelic-centered, therapeutic products and services through its laboratory and research & development processes. The company's clinic network consists of Numinus Health, Mindspace Services, and the Neurology Center of Toronto. Its services include Ketamine-assisted psychotherapy for depression, neurological care, psychotherapy, and counseling by registered psychologists among others. The company's operating segments are; Clinical research operations, Canadian clinic network, US clinic network and Corporate. The majority of the revenue for the company is generated from US clinic network segment. Geographically, the company has its presence in United States and Canada.